OPKO HEALTH INC (OPK)

Overview Price 5.17 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $5.17 Daily Range $0.00 - $0.00 52-Week Range $3.15 - $5.85 Volume 0 eXegenics Inc. is biopharmaceutical company specializing in the development of therapeutic and diagnostic products for human diseases with an emphasis on the treatment and prevention of cancer and infectious diseases. Its research and development activities relate principally to its proprietary Paclitaxel production system using fermentation and genetic engineering in agreements with Bristol-Myers Squibb, the treatment of Polycystic Kidney Disease using paclitaxel, Quantum Core Technology, our proprietary rational drug design targeting the human genome. Other Resources for OPK Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Company News for September 23, 2011 September 23, 2011 Zacks Blog: Company News for March 04, 2011 March 4, 2011 eXegenics Inc. is biopharmaceutical company specializing in the development of therapeutic and diagnostic products for human diseases with an emphasis on the treatment and prevention of cancer and infectious diseases. Its research and development activities relate principally to its proprietary Paclitaxel production system using fermentation and genetic engineering in agreements with Bristol-Myers Squibb, the treatment of Polycystic Kidney Disease using paclitaxel, Quantum Core Technology, our proprietary rational drug design targeting the human genome.   Brokerage Analyst Recommendations 2 Brokerage Firms Covering OPK   Strong Buy 2 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   OPK Ratings: BUY  SELL  HOLD OPK Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 5 Buy 0 Sell   Top Buy Analysis BUY: OPK Company: OPKO HEALTH INC Points: 84.47 Start Price: $2.42 Start Date: 09/27/2009 10:14 AM iblcpro P&P Score: 28.76 Recs: End target 6.5$ Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
rjm77me	99.92	06/24/11	Notable insider buying / selling info for week:	0
PaulShark	1.27	12/29/10	W.O.M. WORLD OF MEDICINE AG 40 years track record in medical devices	0
Zacks_Analysts	0.00	10/15/09	Schering Inks Deal With Opko - Analyst Blog	0

Commentary

BUY: OPKO HEALTH INC (OPK) Start Price: $2.42 Points: +84.47 Created: 09/27/2009 End target 6.5$ Comments: 0 | Comment iblcpro Recs:

BUY: OPKO HEALTH INC (OPK) Start Price: $1.49 Points: +210.23 Created: 10/20/2008 Comments: 0 | Comment Revolver Recs:

BUY: OPKO HEALTH INC (OPK) Start Price: $1.54 Points: +198.95 Created: 10/19/2008 Comments: 0 | Comment AtoZ Recs:

BUY: OPKO HEALTH INC (OPK) Start Price: $1.70 Points: +212.40 Created: 01/01/2008 Comments: 0 | Comment LesterMajkowicz Recs:

BUY: OPKO HEALTH INC (OPK) Start Price: $3.15 Points: +72.25 Created: 01/01/2008 Comments: 0 | Comment molyexpert Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
iblcpro	28.76	BUY	One to Three Years	09/27/2009	$2.42	$5.18 (-0.65%)	+113.89%	+29.42%	+84.47	view close
Revolver	73.61	BUY	Six Months to a Year	10/20/2008	$1.49	$5.18 (-0.65%)	+247.40%	+37.17%	+210.23
AtoZ	62.72	BUY	Three to Six Months	10/19/2008	$1.54	$5.18 (-0.65%)	+236.12%	+37.17%	+198.95
LesterMajkowicz	43.28	BUY	Six Months to a Year	01/01/2008	$1.70	$5.18 (-0.65%)	+204.48%	-7.92%	+212.40
molyexpert	28.79	BUY	Six Months to a Year	01/01/2008	$3.15	$5.18 (-0.65%)	+64.32%	-7.92%	+72.25